Prosecution Insights
Last updated: August 18, 2026

Examiner: DIBRINO, MARIANNE

Tech Center 1600 • Art Units: 1641 1644

This examiner grants 43% of resolved cases

Performance Statistics

43.2%
Allow Rate
-16.8% vs TC avg
656
Total Applications
+41.6%
Interview Lift
1733
Avg Prosecution Days
Based on 627 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
18.7%
§102 Novelty
25.0%
§103 Obviousness
35.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17018681 UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORS Non-Final OA The Research Institute at Nationwide Children's Hospital
18238045 METHODS FOR REDUCING ALLERGIES CAUSED BY ENVIRONMENTAL ALLERGENS Non-Final OA Société des Produits Nestlé S.A.
18351087 HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES Non-Final OA The Johns Hopkins University
18189433 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS Non-Final OA Seattle Children's Hospital (dba Seattle Children's Research Institute)

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month